MC38-hEpCAM
Strain Information
Validation Data
Fig1. hEpCAM expression on in vitro cultured cells of MC38-hEpCAM.
Fig2. In vivo validation of MC38-hEpCAM in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-hEpCAM subcutaneously at 1×106 cells/mouse inoculum for tumor development.
Fig3. hEpCAM expression in tumors after in vivo growth of MC38-hEpCAM in wild type C57BL/6 mice. The tumors were collected at day 28 post tumor cell inoculation.
Fig4. hEpCAM expression in tumors after in vivo growth of MC38-hEpCAM in wild type C57BL/6 mice. The tumors were collected at day 37 post tumor cell inoculation.
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more